Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name?

Biochemical and Biophysical Research Communications

Volumn 355, Issue 4, 2007, Pages 855-859

  Neuzil, Jiri ^a,b   Stantic, Marina ^a   Zobalova, Renata ^a,b   Chladova, Jaromira ^b   Wang, Xiufang ^a   Prochazka, Lubomir ^a,c   Dong, Lanfeng ^a   Andera, Ladislav ^b   Ralph, Stephen J ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

CD133; Resistance to treatment; Tumour initiating cells

Indexed keywords

CD133 ANTIGEN;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CELL ORGANELLE; CELL PROLIFERATION; GENE TARGETING; HUMAN; MITOCHONDRION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; TUMOR CELL;

ANIMALS; ANTIGENS, CD; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; NEOPLASMS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 33847649534     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.159     Document Type: Short Survey

References (55)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. D'Amour K.A., and Gage F.H. Are somatic stem cells pluripotent or lineage-restricted?. Nat. Med. 8 (2002) 213-214
3. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
4. Guo Y., Follo M., Geiger K., Lubbert M., and Engelhardt M. Side-population cells from different precursor compartments. J. Hematoth. Stem Cell Res. 12 (2003) 71-82
5. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
6. Bhatia M., Bonnet D., Murdoch B., Gan O.I., and Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4 (1998) 1038-1045
7. Park C.H., Bergsagel D.E., and McCulloch E.A. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl. Cancer Inst. 46 (1971) 411-422
8. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
9. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., Brem H., Olivi A., Dimeco F., and Vescovi A.L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444 (2006) 761-765
10. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14228-14233
11. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2006) 106-110
12. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
13. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland NJ N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65 (2005) 10946-10951
14. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., and Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 351 (2006) 820-824
15. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., Jiang G., Ge C., Xie H., Wan D., Yang S., Zheng S., and Gu J. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 120 (2007) 1436-1442
16. Mackenzie I.C. Stem cell properties and epithelial malignancies. Eur. J. Cancer 42 (2006) 1204-1212
17. Paguirigan A., Beebe D.J., Liu B., and Alexander C. Mammary stem and progenitor cells: tumour precursors?. Eur. J. Cancer 42 (2006) 1225-1236
18. Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?. Med. Hypotheses 66 (2006) 601-604
19. Berger F., Gay E., Pelletier L., Tropel P., and Wion D D. Development of gliomas: potential role of asymmetrical cell division of neural stem cells. Lancet Oncol. 5 (2004) 511-514
20. Finlan L.E., and Hupp T.R. Epidermal stem cells and cancer stem cells: insights into cancer and potential therapeutic strategies. Eur. J. Cancer 42 (2006) 1283-1292
21. Sell S. Potential gene therapy strategies for cancer stem cells. Curr. Gene Ther. 6 (2006) 579-591
22. Huff C.A., Matsui W.H., Douglas Smith B., and Jones R.J. Strategies to eliminate cancer stem cells: clinical implications. Eur. J. Cancer 42 (2006) 1293-1297
23. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., and Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 15178-15183
24. Pilkington G.J. Cancer stem cells in the mammalian central nervous system. Cell Prolif. 38 (2005) 423-433
25. Vescovi A.L., Galli R., and Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 6 (2006) 425-436
26. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
27. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., and Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 439 (2006) 84-88
28. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., and Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117 (2004) 3539-3545
29. Mehra N., Penning M., Maas J., Beerepoot L.V., Van Daal N., Van Gils C.H., Giles R.H., and Voest E.E. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin. Cancer Res. 12 (2006) 4859-4866
30. Shmelkov S.V., St Clair R., Lyden D., and Rafii S S. AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 37 (2005) 715-719
31. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., Bray R.A., Waller E.K., and Buck D.W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90 (1997) 5013-5021
32. Corbeil D., Roper K., Fargeas C.A., Joester A., and Huttner W.B. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2 (2001) 82-91
33. Maw M.A., Corbeil D., Koch J., Hellwig A., Wilson-Wheeler J.C., Bridges R.J., Kumaramanickavel G., John S., Nancarrow D., Roper K., Weigman A., Huttner W.B., and Denton M.J. Hum. Mol. Genet. 9 (2000) 27-34
34. Yu Y., Flint A., Dvorin E.L., and Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J. Biol. Chem. 277 (2002) 20711-20716
35. Fargeas C.A., Florek M., Huttner W.B., and Corbeil D. Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J. Biol. Chem. 278 (2003) 8586-8596
36. M. Florek, N. Bauer, P. Janich, M. Wilsch-Braeuninger, C.A. Fargeas, A.M. Marzesco, G. Ehninger, W.B. Thiele, W.B. Huttner, D. Corbeil, Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine, Cell Tissue Res. in press.
37. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., Sciacca F.L., Ottolina A., Parati E.A., La Porta C., Alessandri G., Marras C., Croci D., and De Rossi M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54 (2006) 850-860
38. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., and Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5 (2006) 67
39. Neuzil J., Weber T., Schröder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Nègre-Salvayre A., Sticha M., Coffey R.J., and Weber C. Induction of apoptosis in cancer cells by α-tocopheryl succinate: Molecular pathways and structural requirements. FASEB J. 15 (2001) 403-415
40. Stapelberg M., Gellert N., Swettenham E., Tomasetti M., Witting P.K., Procopio A., and Neuzil J. α-Tocopheryl succinate inhibits malignant mesothelioma by disrupting the FGF autocrine loop: the role of oxidative stress. J. Biol. Chem. 280 (2005) 25369-25376
41. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmelad A.B., Dewhirst M.W., Bigner D.D., and Rich JN J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
42. Frank N.Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., and Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278 (2003) 47156-47165
43. Frank N.Y., Margaryan A., Huang Y., Schatton T., Waaga-Gasser A.M., Gasser M., Sayegh M.H., Sadee W., and Frank MH M.H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65 (2005) 4320-4333
44. Hambardzumyan D., Squartro M., and Holland EC E.C. Radiation resistance and stem-like cells in brain tumors. Cancer Cell. 10 (2006) 454-456
45. Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y.M., and Eberhart C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66 (2006) 7445-7452
46. Georgia S., Soliz R., Li M., Zhang P., and Bhushan A. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev. Biol. 298 (2006) 22-31
47. Clement V., Sanchez P., De Tribolet N., Radovanovic I., Ruiz I., and Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17 (2007) 165-172
48. Osterlund T., and Kogerman P. Hedgehog signalling: how to get from Smo to Ci and Gli. Trends Cell. Biol. 16 (2006) 176-180
49. Frank Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., and Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278 (2003) 47156-47165
50. Thomas M., Gessner A., Vornlocher H.P., Hadwiger P., Greil J., and Heidenreich O. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 106 (2005) 3559-3566
51. J. Neuzil, M. Tomasetti, Y. Zhao, L.F. Dong, M. Birringer, X.F. Wang, P. Low, K. Wu, B.A. Salvatore, S.J. Ralph, Vitamin E analogs, a novel group of 'mitocans', as anti-cancer agents: the importance of being redox-silent, Mol. Pharmacol., in press.
52. X.F. Wang, M. Birringer, L.F. Dong, P. Veprek, P. Low, S. Swettenham, M. Stanic, L.H. Yuan, R. Zobalova, K. Wu, S.J. Ralph, M. Ledvina, J. Neuzil, A peptide adduct of vitamin E succinate targets breast cancer cells with high erbB2 expression, Cancer Res., in press.
53. Guzman L., Rossi R.M., Karnischky L., Li X., Peterson D.R., Howard D.S., and Jordan C.T. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105 (2005) 4163-4169
54. Brunk U.T., Neuzil J., and Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep. 6 (2001) 91-97
55. Mohamed M.M., and Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6 (2006) 764-775